James R. Hollingshead Ph.D.
Net Worth
Last updated:
What is James R. Hollingshead Ph.D. net worth?
The estimated net worth of Dr. James R. Hollingshead Ph.D. is at least $45,751,813 as of 1 Dec 2021. He owns shares worth $21,765,748 as insider, has earned $6,826,065 from insider trading and has received compensation worth at least $17,160,000 in ResMed Inc..
What is the salary of James R. Hollingshead Ph.D.?
Dr. James R. Hollingshead Ph.D. salary is $1,430,000 per year as Pres of Sleep & Respiratory Care Bus. in ResMed Inc..
How old is James R. Hollingshead Ph.D.?
Dr. James R. Hollingshead Ph.D. is 62 years old, born in 1963.
What stocks does James R. Hollingshead Ph.D. currently own?
As insider, Dr. James R. Hollingshead Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| ResMed Inc. (RMD) | Pres of Sleep & Respiratory Care Bus. | 76,721 | $283.7 | $21,765,748 |
What does ResMed Inc. do?
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
James R. Hollingshead Ph.D. insider trading
ResMed Inc.
Dr. James R. Hollingshead Ph.D. has made 62 insider trades between 2013-2021, according to the Form 4 filled with the SEC. Most recently he sold 2,400 units of RMD stock worth $616,416 on 1 Dec 2021.
The largest trade he's ever made was exercising 22,903 units of RMD stock on 11 Nov 2014. As of 1 Dec 2021 he still owns at least 76,721 units of RMD stock.
ResMed key executives
ResMed Inc. executives and other stock owners filed with the SEC:
- Dr. James R. Hollingshead Ph.D. (62) Pres of Sleep & Respiratory Care Bus.
- Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD (83) Founder & Non-Executive Chairman
- Mr. Brett A. Sandercock (58) Chief Financial Officer
- Mr. Michael J. Farrell BE, MBA, SM (53) Chief Executive Officer & Director
- Mr. Robert A. Douglas (65) Pres & Chief Operating Officer